Trial · NCT03192306
Results by group116
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 116
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Clinician Assessed Duration of the Classical Herpetic Lesion | Merlin | 162.7 | Standard Deviation 68.4 | hours | |
| Clinician Assessed Duration of the Classical Herpetic Lesion | Ethanol | 163.6 | Standard Deviation 74.9 | hours | |
| Clinician Assessed Duration of the Herpetic Episode | Merlin | 151.1 | Standard Deviation 70.9 | hours | |
| Clinician Assessed Duration of the Herpetic Episode | Ethanol | 158.6 | Standard Deviation 74.5 | hours | |
| Clinician Assessed Duration Until Complete Healing of the Herpetic Episode | Merlin | 223.4 | Standard Deviation 83.2 | hours | |
| Clinician Assessed Duration Until Complete Healing of the Herpetic Episode | Ethanol | 222.0 | Standard Deviation 86.4 | hours | |
| Clinician Assessed Prevention of Progression to Classical Lesion | Merlin | 12 | Participants | ||
| Clinician Assessed Prevention of Progression to Classical Lesion | Ethanol | 6 | Participants | ||
| Clinician Assessed Lesion Size | Merlin | 46.8 | Standard Deviation 50.2 | square mm | |
| Clinician Assessed Lesion Size | Ethanol | 36.2 | Standard Deviation 43.7 | square mm | |
| Clinician Assessed Duration of the Herpetic Lesion Hard Scab | Merlin | 66.6 | Standard Deviation 56.8 | hours | |
| Clinician Assessed Duration of the Herpetic Lesion Hard Scab | Ethanol | 65.9 | Standard Deviation 62.3 | hours | |
| Subject Assessed Duration of Pain | Merlin | First Treatment / No Pain | 31 | Participants | |
| Subject Assessed Duration of Pain | Ethanol | First Treatment / No Pain | 35 | Participants | |
| Subject Assessed Duration of Pain | Merlin | First Treatment / Mild | 40 | Participants | |
| Subject Assessed Duration of Pain | Ethanol | First Treatment / Mild | 37 | Participants | |
| Subject Assessed Duration of Pain | Merlin | First Treatment / Moderate | 4 | Participants | |
| Subject Assessed Duration of Pain | Ethanol | First Treatment / Moderate | 7 | Participants | |
| Subject Assessed Duration of Pain | Merlin | First Treatment / Severe | 0 | Participants | |
| Subject Assessed Duration of Pain | Ethanol | First Treatment / Severe | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03192306/results